Table 3.
COH cycle characteristics of patients who underwent a cycle specific vs. random start protocol and completed an oocyte retrieval
| Stimulation Measures (n=195a) |
Cycle Specific (n=173) |
Random Start (n=22) |
P value |
|---|---|---|---|
|
| |||
| Age | |||
| Median (Range) |
31 (15–42) |
30 (19–39) |
NS |
|
| |||
| BMI | |||
| Median (Range) |
22.96 (17.69–61.27) |
24.59 (16.20–34.40) |
NS |
|
| |||
| AMH (ng/ml) | |||
| Median (Range) |
1.70 (0–10.70) |
4.33 (0–10.39) |
NS |
|
| |||
| Peak Estradiol (pg/ml) | |||
| Median (Range) |
1445 (109–3518) |
1336 (55–4341) |
NS |
|
| |||
| Number of days of stimulation | |||
| Median (Range) |
10 (6–16) |
10 (7–15) |
NS |
|
| |||
| Total FSH Dosage | |||
| Median (Range) |
2100 (300–7500) |
1525 (750–5400) |
NS |
|
| |||
| Total HMG Dosage | |||
| Median (Range) |
825 (225–2850) |
750 (600–1800) |
NS |
|
| |||
| Total number of oocytes Retrieved | |||
| Median (Range) |
11 (0–55) |
13 (1–30) |
NS |
|
| |||
| Number of mature oocytes | |||
| Median (Range) |
8 (0–40) |
10 (1–21) |
NS |
|
| |||
| Number of oocytes cryopreserved | |||
| Median (Range) |
9 (0–37) |
12 (0–25) |
NS |
|
| |||
| Number of embryos cryopreserved | |||
| Median (Range) |
6 (0–16) |
6 (0–16) |
NS |
|
| |||
| Number of days to next cancer treatment (after PN meeting)b | n=132 | n=18 | |
| Median (Range) |
33 (16–95) |
36 (16–85) |
NS |
AMH, anti-Müllerian hormone; BMI, body mass index; COH, controlled ovarian hyperstimulation; E2, estradiol; HMG, human menotropin gonadotropin; PN, patient navigator.
a
n=9 started but did not complete full stimulation cycle. These patients were not included in Table 3.
b
n=29 did not have next treatment date available in our records; n=16 >100d until next treatment, thus not included in this analysis.